Hisamitsu Pharmaceutical Co Stock Performance
| HTSUF Stock | USD 24.56 0.86 3.63% |
The company retains a Market Volatility (i.e., Beta) of -0.46, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Hisamitsu Pharmaceutical are expected to decrease at a much lower rate. During the bear market, Hisamitsu Pharmaceutical is likely to outperform the market. Hisamitsu Pharmaceutical has an expected return of -1.2%. Please make sure to check out Hisamitsu Pharmaceutical jensen alpha, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to decide if Hisamitsu Pharmaceutical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Hisamitsu Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in May 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 91.4 B | |
| Total Cashflows From Investing Activities | -13.1 B |
Hisamitsu |
Hisamitsu Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 2,578 in Hisamitsu Pharmaceutical Co on January 25, 2024 and sell it today you would lose (122.00) from holding Hisamitsu Pharmaceutical Co or give up 4.73% of portfolio value over 90 days. Hisamitsu Pharmaceutical Co is currently producing negative expected returns and takes up 1.3944% volatility of returns over 90 trading days. Put another way, 12% of traded pink sheets are less volatile than Hisamitsu, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Hisamitsu Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hisamitsu Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Hisamitsu Pharmaceutical Co, and traders can use it to determine the average amount a Hisamitsu Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.8587
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HTSUF |
Estimated Market Risk
| 1.39 actual daily | 12 88% of assets are more volatile |
Expected Return
| -1.2 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.86 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Hisamitsu Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hisamitsu Pharmaceutical by adding Hisamitsu Pharmaceutical to a well-diversified portfolio.
Hisamitsu Pharmaceutical Fundamentals Growth
Hisamitsu Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Hisamitsu Pharmaceutical, and Hisamitsu Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Hisamitsu Pink Sheet performance.
| Return On Equity | 0.0504 | |||
| Return On Asset | 0.0212 | |||
| Profit Margin | 0.10 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 1.15 B | |||
| Shares Outstanding | 79.53 M | |||
| Price To Earning | 22.53 X | |||
| Price To Book | 0.97 X | |||
| Price To Sales | 0.02 X | |||
| Revenue | 120.19 B | |||
| EBITDA | 17.3 B | |||
| Cash And Equivalents | 151.32 B | |||
| Total Debt | 219 M | |||
| Debt To Equity | 0 % | |||
| Book Value Per Share | 3,393 X | |||
| Cash Flow From Operations | 19.2 B | |||
| Earnings Per Share | 1.06 X | |||
| Total Asset | 302.86 B | |||
| Retained Earnings | 216.56 B | |||
| Current Asset | 171.81 B | |||
| Current Liabilities | 37.93 B | |||
About Hisamitsu Pharmaceutical Performance
To evaluate Hisamitsu Pharmaceutical Pink Sheet as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Hisamitsu Pharmaceutical generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Hisamitsu Pink Sheet's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Hisamitsu Pharmaceutical market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Hisamitsu's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. Hisamitsu Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 2784 people.Things to note about Hisamitsu Pharmaceutical performance evaluation
Checking the ongoing alerts about Hisamitsu Pharmaceutical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Hisamitsu Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Hisamitsu Pharmaceutical is not yet fully synchronised with the market data | |
| Hisamitsu Pharmaceutical generated a negative expected return over the last 90 days | |
| About 26.0% of the company shares are held by company insiders |
- Analyzing Hisamitsu Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Hisamitsu Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Hisamitsu Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Hisamitsu Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Hisamitsu Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Hisamitsu Pharmaceutical's pink sheet. These opinions can provide insight into Hisamitsu Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Hisamitsu Pink Sheet analysis
When running Hisamitsu Pharmaceutical's price analysis, check to measure Hisamitsu Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hisamitsu Pharmaceutical is operating at the current time. Most of Hisamitsu Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Hisamitsu Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hisamitsu Pharmaceutical's price. Additionally, you may evaluate how the addition of Hisamitsu Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |